Menopause Scams to Watch Out For, According to a Doctor

In other words, it’s a wild ride. And these days, entrepreneurs are cashing in. A huge influx of products targeted at menopausal women has hit the market in recent years. You can now, for instance, buy clothing specially designed to relieve hot flashes and other menopause symptoms, or you can shop for beauty brands focused on menopausal health.
But unlike, say, cold plunges or red light therapy, menopause is not some fleeting wellness trend. This is a real and often bewildering phase of life for women, one that has been largely misunderstood or outright ignored for too many years. With so many products now on the market, what’s the best way to tell what’s legit and what’s not?
Lisa Larkin, MD, is a board-certified internist practicing internal medicine and women’s health in Cincinnati, Ohio. She’s watched with interest — and, often, concern — as menopause has gone from a little-discussed topic to the buzzword it is today. “I call it ‘meno profiteering,’” she says. “There’s so much stuff out there being sold that doesn’t have data behind it. I really feel like women are being taken advantage of.”
Everyday Health spoke with Dr. Larkin about the rise of Menopause Inc. — the good, the harmless (but ultimately useless), and the scammy.
Everyday Health: What do you make of the fact that menopause is having a moment? Why now?
Dr. Lisa Larkin: So I’m an old doctor now, right? I’ve been practicing for [over] 32 years. And I have to tell you, hormone therapy has defined my professional career.
When I started practicing, the data was all pro-hormones. I was giving all my patients hormones, because we believed hormones benefited women — even women at high risk of cardiovascular disease. We believed more women benefited from hormones than were harmed.
I just cringe every day. You’ve got very influential celebrities touting products that have no data.
EH: What are some red flags to look out for when evaluating menopause products on the market?
LL: I want to start with supplements, because that’s really what you need to be most skeptical about. When you’re looking at the ingredients, if you see a phrase like “proprietary blend,” that means you don’t really know what’s in there. That’s a huge red flag for me.
Supplements are generally safe for healthy people. They’re probably not doing anything harmful — you’re just making expensive urine. For a 35-year-old who is healthy and on no medications, taking supplements is probably not harmful, even these ones with a proprietary blend.
But where I get concerned is for patients who are on medications. When you have a breast cancer survivor who’s on five different medications, we have no idea what those drugs are doing in combination with these supplements. If you’re a patient who has health issues and is on other drugs, I really encourage you not to buy supplements online and to have a physician involved in your care.
EH: What about beauty products? Any potential harm there?
LL: I have less of an issue with somebody putting stuff on their face, in terms of the safety. I tell my patients to focus on what has the data. You don’t need all this expensive stuff. But if you like the smell, if you like the way it feels — fine.
I have less concern about the topical products — even topical estrogen. I would still tell you I would not recommend those for a breast cancer survivor, especially one who is on other medications. But the dosing is so low that it probably is not harmful.
EH: How about sexual health products aimed at menopausal women?
Where the data starts to fall apart — and where we, again, get into this “meno profiteering” space — is in all of these vaginal rejuvenation devices, like the vaginal laser or vaginal steaming. These treatments are also largely not harmful. But I do believe people are profiting off these things without good data to back them up.
EH: What about over-the-counter tests? Useful or scammy?
LL: Here’s the story: You don’t need those tests, okay?
There are some out there right now where you can check your hormones over several days to try to get some information about where you are in the perimenopause-to-menopause transition. And this generation of 38- to 42-year-olds — they love their data. Everyone has wearable devices or continuous glucose monitors, or they’re tracking their sleep. People want data, which is why these over-the-counter tests sell.
But the truth is, hormone levels in early and late perimenopause change day to day — they’re going to be all over the place. So you don’t need the test. I also don’t think it’s harmful — it’s not hurting anybody. But do you need it? I don’t think so.
EH: What are some green flags — things to look for that may signal a product is worth trying?
Larkin: See if there is any data or publications related to the product, though that’s very hard for most people to do on their own. But you can also look for single-ingredient products — again, not products with “proprietary blend” in the ingredients list. And if you have other health conditions or are on medications, I encourage you to talk to a doctor before you try something.
EH: It’s such a confusing time of life for so many women. What else should they keep in mind as they try to navigate it?
LL: Don’t suffer in silence. Really try to find a physician who can address your needs, because there really is evidence-based help available. Women fall through the healthcare cracks between 40 and 60, because they’re generally healthy, and they don’t have many points of contact with physicians. But that’s when things like cardiovascular risk or prediabetes can develop. It’s so important for women to get good medical care in midlife, and I would really encourage women to advocate for themselves.
The Takeaway
- Avoid supplements with phrases like “proprietary blend” in the ingredients list.
- Most cosmetics targeted at menopausal women are not harmful, but most aren’t worth the money either.
- If you’re on other medications, it’s a good idea to check with your doctor before trying any supplement or topical product.
- Dalvi SA. Menopause: Why Is Everyone Talking About It Now? The Journal of Obstetrics and Gynecology of India. June 27, 2024.
- Menopause Market (2025-2030): Size, Share and Trends Analysis Report by Treatment (Dietary Supplements, OTC Pharma Products), by Region (NA, Europe, APAC, Latin America, MEA), and Segment Forecasts. Grand View Research. April 2025.
- Perimenopause. Cleveland Clinic. August 8, 2024.
- Cagnacci A et al. The Controversial History of Hormone Replacement Therapy. Medicina (Kaunas). September 18, 2019.
- Berman K. After Decades of Misunderstanding, Menopause Is Finally Having Its Moment. Yale School of Medicine. April 14, 2025.
- Vale F et al. Efficacy and Safety of a Non-Hormonal Intravaginal Moisturizer for the Treatment of Vaginal Dryness in Postmenopausal Women With Sexual Dysfunction. European Journal of Obstetrics & Gynecology and Reproductive Biology. March 2019.

Kara Smythe, MD
Medical Reviewer
Kara Smythe, MD, has been working in sexual and reproductive health for over 10 years. Dr. Smythe is a board-certified fellow of the American College of Obstetricians and Gynecologists, and her interests include improving maternal health, ensuring access to contraception, and promoting sexual health.
She graduated magna cum laude from Florida International University with a bachelor's degree in biology and earned her medical degree from St. George’s University in Grenada. She completed her residency in obstetrics and gynecology at the SUNY Downstate Medical Center in Brooklyn, New York. She worked in Maine for six years, where she had the privilege of caring for an underserved population.
Smythe is also passionate about the ways that public health policies shape individual health outcomes. She has a master’s degree in population health from University College London and recently completed a social science research methods master's degree at Cardiff University. She is currently working on her PhD in medical sociology. Her research examines people's experiences of accessing, using, and discontinuing long-acting reversible contraception.
When she’s not working, Smythe enjoys dancing, photography, and spending time with her family and her cat, Finnegan.

Melissa Dahl
Author
Melissa Dahl is an award-winning journalist with more than 15 years of experience covering health, with a focus on mental health, fitness, sexual health, and women's health. She's also the author of Cringeworthy: A Theory of Awkwardness, which was published by Penguin Random House in 2018 and translated into six languages. In 2023, an editorial package she helped lead for Romper won Best Service Journalism from the American Society of Magazine Editors.
Dahl is also a running coach, specializing in new and returning runners, with a certification from the Road Runners Club of America.